LARP6, a member of the La-associated protein (LARP) family, is aberrantly expressed in MDA-MB-231 breast cancer cells, resulting in a series of physiological responses with enhanced invasive behavior in in vitro and in vivo xenograft models, including proliferation, platelet pseudopod formation, EMT, invasion, MMP-9 and VEGF expression, angiogenesis and tumor growth (57). This evidence concerns the gene LARP6 and breast cancer.